Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients

prnasiaJanuary 11, 2021

Tag: Proxalutamide , Kintor , COVID-19 , Clinical Trial

PharmaSources Customer Service